BPC-157 + TB-500

This blend combines BPC-157, a gastric pentadecapeptide studied for cytoprotective properties, with TB-500, a synthetic fragment of Thymosin Beta-4 studied for cell migration and tissue remodeling. The combination allows researchers to probe mechanistic overlap between BPC-157's proposed angiogenic properties and TB-500's role in actin regulation and wound healing signaling.

Research applications include comparative tissue repair pharmacology, dual-pathway wound healing models, tendon and connective tissue biology, and angiogenesis studies. The blend design allows researchers to study synergistic or additive effects between cytoprotective (BPC-157) and cytoskeletal remodeling (TB-500) mechanisms.

Each component is independently synthesized and analyzed by third-party HPLC before co-lyophilization. We guarantee ≥99% purity for each component individually. Full chromatograms are documented in the Certificate of Analysis.

This product is strictly for research and laboratory use only. It is not approved by the FDA or any global regulatory body for human consumption, veterinary use, or therapeutic application. The purchaser assumes all responsibility for the proper handling, storage, and application of this compound. It must only be handled by qualified professionals in a controlled laboratory setting. By purchasing this product, you agree to abide by all local and international laws regarding the use of research chemicals.